Active ingredientElvitegravirCat. No. P-E030-001CAS 697761-98-1Family · Pharmaceutical analytical standards
Elvitegravir
An inhibitor of HIV integrase, the enzyme that inserts the virus genome into the cell's DNA: approved in the United States in August 2012 in a fixed-dose combination with cobicistat, emtricitabine and tenofovir, in a single tablet. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It shares its core structure with the quinolone antibiotics: a chemical scaffold created to hit a bacterial enzyme was adapted to block a viral one.
Go to the active ingredient →Active ingredientElvitegravirCat. No. P-E030-001CAS 697761-98-1
MetaboliteElvitegravir Acyl GlucuronideCat. No. P-E030-002CAS 870649-25-5
Isotopically labelledElvitegravir-d8Cat. No. P-E030-004
Impurity2-Chloro-3-Fluoro ElvitegravirCat. No. P-E030-005CAS 2726921-70-4
ImpurityElvitegravir Impurity 1Cat. No. P-E030-006CAS 949465-79-6
ImpurityElvitegravir Impurity 2Cat. No. P-E030-007CAS 697762-60-0
ImpurityL-ValinolCat. No. P-E030-008CAS 2026-48-4
Impuritypara-Hydroxy ElvitegravirCat. No. P-E030-009CAS 870648-10-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.